Pharmacology, Toxicology and Pharmaceutical Science
Pharmacokinetics
73%
Antiinfective Agent
64%
Pharmacodynamics
50%
Ventilator Associated Pneumonia
48%
Infection
48%
Disease
33%
Antibiotics
31%
Coronavirinae
31%
Piperacillin
27%
Meningoencephalitis
25%
Piperacillin Plus Tazobactam
24%
Adverse Event
23%
Antibiotic Agent
23%
Antifungal Agent
20%
Beta Lactam
18%
Asthma
18%
Infectious Agent
16%
Sepsis
16%
Normal Human
16%
Therapeutic Drug Monitoring
14%
Invasive Aspergillosis
14%
Aminoglycoside
14%
Tazobactam
13%
Hospital Infection
12%
Blood Clotting Disorder
12%
Amphotericin B
12%
SARS Coronavirus
12%
Volatile Organic Compound
12%
Isavuconazole
12%
Voriconazole
12%
Von Willebrand Factor Cleaving Proteinase
12%
Von Willebrand Factor
12%
Vancomycin
12%
Acute Kidney Failure
12%
Inflammation
11%
Colistimethate
11%
Respiratory Tract
11%
Hospital Acquired Pneumonia
11%
Cefepime
11%
Aspergillus
10%
Pharmacodynamic Parameter
10%
Antimicrobial Therapy
9%
Clinical Study
9%
Pharmacokinetics
9%
Respiratory Tract Infection
9%
Triazole
8%
Controlled Clinical Trial
8%
Antifungal Therapy
8%
Candida
8%
Immunocompromised Patient
8%
Medicine and Dentistry
COVID-19
100%
Ventilator-Associated Pneumonia
39%
Antiinfective Agent
29%
Sepsis
29%
Intensive Care
26%
Anti-biotics
25%
Infection
22%
Meta-Analysis
22%
Cohort Analysis
18%
Extracorporeal Membrane Oxygenation
18%
Breathing
16%
Pharmacokinetics
16%
Pharmacodynamics
16%
Bloodstream Infection
16%
Artificial Respiration
16%
Diagnosis
15%
Asthma
14%
Odds Ratio
14%
Aminoglycoside
14%
Colistimethate
14%
T Cell
13%
Tracheobronchial Toilet
13%
Respiratory Failure
13%
Beta Lactam
12%
Pleurodesis
12%
Pneumothorax
12%
COVID-19 Therapy
12%
Multidrug-Resistant Gram-Negative Bacteria
12%
Von Willebrand Factor Cleaving Proteinase
12%
Coagulopathy
12%
B Cell
12%
Von Willebrand Factor
12%
Cross-Link
12%
Mental Capacity
12%
Diagnostic Test
12%
Fibrinolysis
12%
Candidemia
12%
Cell Function
12%
Tocilizumab
12%
Pathogen
12%
Adverse Event
11%
Hospital-Acquired Pneumonia
11%
Antimicrobial Therapy
9%
Aspergillus
8%
Dyspnea
8%
Antibiotic Therapy
8%
Antifungal Agent
8%
Lung Lavage
8%
Noninvasive Ventilation
8%
Observational Study
8%
Immunology and Microbiology
COVID-19
56%
Asthma
26%
Pharmacodynamics
18%
Mental Capacity
14%
T Cell
14%
Medline
13%
Cochrane Library
13%
Pharmacokinetics
13%
Fibrinolysis
12%
Minimum Concentration
12%
Cross Linking
12%
Cell Function
12%
Phenotype
12%
B Cell
12%
Sputum
12%
Minimum Inhibitory Concentration
10%
Antimicrobial Resistance
10%
Severe Acute Respiratory Syndrome Coronavirus 2
8%
Immune Response
7%
Ampicillin Resistance
6%
Organoid
6%
Pseudomonas aeruginosa
6%
Enterobacter Cloacae
6%
Kidney Transplantation
6%
Colistin
6%
Candida
6%
Gram-Negative Bacteria
6%
Allergic Bronchopulmonary Aspergillosis
6%
Interleukin-6 Receptor
6%
Tocilizumab
6%
Mortality
6%
Maximum Concentration
6%
Myeloid
6%
Induced Pluripotent Stem Cell
6%
Meropenem/Vaborbactam
6%
Nebulization
6%
Humor
6%
Aspergillus fumigatus
6%
Microbiome
6%
Coculture
6%
Carbapenem Resistant Enterobacteriaceae
6%
Wild Type
6%
Sarilumab
6%
Escherichia coli
6%
TLR7
6%
Data Synthesis
6%
Blood Plasma
5%
Antifungal Activity
5%
Normal Human
5%